Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid.
J Eur Acad Dermatol Venereol
; 37(6): e695-e697, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-36786360
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
4_TD
Database:
MEDLINE
Main subject:
Immunization, Secondary
/
Pemphigoid, Bullous
/
Pemphigus
/
COVID-19 Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Year:
2023
Document type:
Article